Patents Assigned to Ryogen LLC
  • Patent number: 8399639
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the p15 arm of chromosome 11 encoding HASH2 and methods of use.
    Type: Grant
    Filed: September 21, 2011
    Date of Patent: March 19, 2013
    Assignee: Ryogen LLC
    Inventor: James Ryan
  • Patent number: 8372588
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human resistin and human syntaxin binding protein 2, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human resistin and human syntaxin binding protein 2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: September 3, 2011
    Date of Patent: February 12, 2013
    Assignee: Ryogen LLC
    Inventor: James Ryan
  • Patent number: 8338100
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: September 24, 2011
    Date of Patent: December 25, 2012
    Assignee: Ryogen LLC
    Inventor: James Ryan
  • Patent number: 8323884
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human SNARE YKT6, human glucokinase, human adipocyte enhancer binding protein (AEBP1) and DNA directed 50 kD regulatory subunit (POLD2), vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain SNARE YKT6, human glucokinase, AEBP1 protein and POLD2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: December 4, 2012
    Assignee: Ryogen LLC
    Inventor: James Ryan
  • Patent number: 8313900
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human SNARE YKT6, human glucokinase, human adipocyte enhancer binding protein (AEBP1) and DNA directed 50kD regulatory subunit (POLD2), vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain SNARE YKT6, human glucokinase, AEBP1 protein and POLD2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: November 20, 2012
    Assignee: Ryogen LLC
    Inventor: James Ryan
  • Patent number: 8313910
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: November 20, 2012
    Assignee: Ryogen LLC
    Inventor: James W Ryan
  • Patent number: 8313899
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human SNARE YKT6, human glucokinase, human adipocyte enhancer binding protein (AEBP1) and DNA directed 50kD regulatory subunit (POLD2), vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain SNARE YKT6, human glucokinase, AEBP1 protein and POLD2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: November 20, 2012
    Assignee: Ryogen LLC
    Inventor: James Ryan
  • Publication number: 20120283425
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human lipoprotein-associated phospholipase A2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Application
    Filed: July 23, 2012
    Publication date: November 8, 2012
    Applicant: RYOGEN LLC
    Inventor: James W. Ryan
  • Patent number: 8283118
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human resistin and human syntaxin binding protein 2, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human resistin and human syntaxin binding protein 2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: September 25, 2011
    Date of Patent: October 9, 2012
    Assignee: Ryogen LLC
    Inventor: James Ryan
  • Patent number: 8241849
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human lipoprotein-associated phospholipase A2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: November 25, 2008
    Date of Patent: August 14, 2012
    Assignee: Ryogen LLC
    Inventor: James W Ryan
  • Patent number: 8178662
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human SNARE YKT6, human glucokinase, human adipocyte enhancer binding protein (AEBP1) and DNA directed 50 kD regulatory subunit (POLD2), vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain SNARE YKT6, human glucokinase, AEBP1 protein and POLD2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: May 15, 2012
    Assignee: Ryogen LLC
    Inventor: James Ryan
  • Publication number: 20120053232
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human and tumor suppressing subtransferable candidate 4 (TSSC4) and methods of use.
    Type: Application
    Filed: September 24, 2011
    Publication date: March 1, 2012
    Applicant: RYOGEN LLC
    Inventor: James W. Ryan
  • Publication number: 20120016008
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human ribosomal protein L26 (RIBO26) and methods of use.
    Type: Application
    Filed: September 24, 2011
    Publication date: January 19, 2012
    Applicant: RYOGEN LLC
    Inventor: James W. Ryan
  • Publication number: 20120010269
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human SMS3 (SMS3) and methods of use.
    Type: Application
    Filed: September 21, 2011
    Publication date: January 12, 2012
    Applicant: RYOGEN LLC
    Inventor: James W. Ryan
  • Publication number: 20120010270
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 6 and methods of use.
    Type: Application
    Filed: September 24, 2011
    Publication date: January 12, 2012
    Applicant: RYOGEN LLC
    Inventor: James W. Ryan
  • Publication number: 20120010275
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the p15 arm of chromosome 11 and methods of use.
    Type: Application
    Filed: September 18, 2011
    Publication date: January 12, 2012
    Applicant: RYOGEN LLC
    Inventor: James W. Ryan
  • Publication number: 20120010268
    Abstract: Provided herein are isolated genomic polynucleotide fragments from the p15 arm of chromosome 11 encoding HASH2 and methods of use.
    Type: Application
    Filed: September 21, 2011
    Publication date: January 12, 2012
    Applicant: RYOGEN LLC
    Inventor: James W. Ryan
  • Patent number: 8058052
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: June 8, 2010
    Date of Patent: November 15, 2011
    Assignee: Ryogen LLC
    Inventor: James W Ryan
  • Patent number: 8057998
    Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human resistin and human syntaxin binding protein 2, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human resistin and human syntaxin binding protein 2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
    Type: Grant
    Filed: November 24, 2008
    Date of Patent: November 15, 2011
    Assignee: Ryogen LLC
    Inventor: James W Ryan
  • Patent number: 8039602
    Abstract: The invention is directed to isolated genomic polynucleotide fragments from the p15 arm of chromosome 11.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: October 18, 2011
    Assignee: Ryogen LLC
    Inventor: James W. Ryan